Pacer Advisors, Inc. G1 Therapeutics, Inc. Transaction History

Pacer Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$19.57 - $26.32 $65,872 - $88,593	-3,366 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$17.58 - $32.59 $12,481 - $23,138	-710 Reduced 17.42%	3,366 $81,000
Q4 2020 Jan 20, 2021	BUY	$10.99 - $20.4 $30,398 - $56,426	2,766 Added 211.15%	4,076 $73,000
Q3 2020 Oct 19, 2020	BUY	$11.55 - $23.75 $15,130 - $31,112	1,310 New	1,310 $15,000
Q4 2018 Feb 13, 2019	SELL	$16.51 - $51.33 $35,100 - $109,127	-2,126 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$43.15 - $67.97 $91,736 - $144,504	2,126 New	2,126 $111,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.